From the AGA Journals
From the Journals
Mentorship key to improving GI, hepatology workforce diversity
A collaboration of five gastroenterology and hepatology medical organizations presented findings on workforce perspectives on diversity and how to...
From the AGA Journals
Looking for the source of neuroendocrine tumors
The research could eventually lead to identification of unique cells-of-origin for these tumors – as well as potential treatment targets.
From the AGA Journals
Experts refine nomenclature for eosinophilic GI diseases
The consensus paper defines subtypes for clinical and research purposes.
From the AGA Journals
Experts refine nomenclature for eosinophilic GI disorders
The consensus paper defines subtypes for clinical and research purposes.
From the Journals
AGA Clinical Practice Update: Expert review of management of subepithelial lesions
SELs represent a heterogeneous group of lesions such as ectopic pancreatic tissue and tumors, and choice of management depends on several...
News
AGA Clinical Practice Update: Expert review of management of refractory celiac disease
Refractory celiac disease can be challenging to diagnose and treat.
From the AGA Journals
Complete endoscopic healing key when stopping anti-TNFs in IBD
In patients with remitting inflammatory bowel disease, relapse after withdrawal of anti-tumor necrosis factor therapy is less likely if they have...
From the AGA Journals
Ustekinumab has comparatively low infection rate in IBD
The biologic was associated with reduced infection risk when compared with anti-TNF agents or tofacitinib in a real-world analysis of nearly 90...
From the AGA Journals
Usefulness of IBD biomarker may vary based on microbiome
Microbiome-based calibration could improve sensitivity and specificity, which could improve efforts to monitor disease activity.
From the AGA Journals
Inhibiting adenosine pathways may be key to CRC treatment
New research suggests mechanisms behind how adenosine leads to immunosuppression in the tumor microenvironment.